status: 200
content-location: http://rest.kegg.jp/get/map05031
server: Apache
date: Wed, 15 Oct 2014 15:09:17 GMT
content-type: text/plain

ENTRY       map05031                    Pathway
NAME        Amphetamine addiction
DESCRIPTION Amphetamine is a psychostimulant drug that exerts persistent addictive effects. Most addictive drugs increase extracellular concentrations of dopamine (DA) in nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), projection areas of mesocorticolimbic DA neurons and key components of the "brain reward circuit". Amphetamine achieves this elevation in extracellular levels of DA by promoting efflux from synaptic terminals. Acute administration of amphetamine induces phosphorylation of cAMP response element-binding protein (CREB) and expression of a number of immediate early genes (IEGs), such as c-fos. The IEGs is likely to initiate downstream molecular events, which may have important roles in the induction and maintenance of addictive states. Chronic exposure to amphetamine induces a unique transcription factor delta FosB, which plays an essential role in long-term adaptive changes in the brain.
CLASS       Human Diseases; Substance dependence
PATHWAY_MAP map05031  Amphetamine addiction
DBLINKS     GO: 0001975
REFERENCE   PMID:16724157
  AUTHORS   Rajadhyaksha AM, Kosofsky BE
  TITLE     Psychostimulants, Protein phosphorylation and Gene expression: a growing role of  L-type calcium channels.
  JOURNAL   Cellscience 2:127-144 (2005)
REFERENCE   PMID:18440072
  AUTHORS   Cunha-Oliveira T, Rego AC, Oliveira CR
  TITLE     Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
  JOURNAL   Brain Res Rev 58:192-208 (2008)
REFERENCE   PMID:16776597
  AUTHORS   Hyman SE, Malenka RC, Nestler EJ
  TITLE     Neural mechanisms of addiction: the role of reward-related learning and memory.
  JOURNAL   Annu Rev Neurosci 29:565-98 (2006)
REFERENCE   PMID:16151049
  AUTHORS   Rajadhyaksha AM, Kosofsky BE
  TITLE     Psychostimulants, L-type calcium channels, kinases, and phosphatases.
  JOURNAL   Neuroscientist 11:494-502 (2005)
REFERENCE   PMID:14622123
  AUTHORS   Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C
  TITLE     Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.
  JOURNAL   J Neurochem 87:922-34 (2003)
REFERENCE   PMID:10414964
  AUTHORS   Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C
  TITLE     L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation  and c-fos gene expression in striatal neurons.
  JOURNAL   J Neurosci 19:6348-59 (1999)
REFERENCE   PMID:8753884
  AUTHORS   Konradi C, Leveque JC, Hyman SE
  TITLE     Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.
  JOURNAL   J Neurosci 16:4231-9 (1996)
REFERENCE   PMID:10774721
  AUTHORS   Berke JD, Hyman SE
  TITLE     Addiction, dopamine, and the molecular mechanisms of memory.
  JOURNAL   Neuron 25:515-32 (2000)
REFERENCE   PMID:17728700
  AUTHORS   McClung CA, Nestler EJ
  TITLE     Neuroplasticity mediated by altered gene expression.
  JOURNAL   Neuropsychopharmacology 33:3-17 (2008)
REFERENCE   PMID:14746512
  AUTHORS   Chao J, Nestler EJ
  TITLE     Molecular neurobiology of drug addiction.
  JOURNAL   Annu Rev Med 55:113-32 (2004)
REFERENCE   PMID:19199083
  AUTHORS   Robertson SD, Matthies HJ, Galli A
  TITLE     A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.
  JOURNAL   Mol Neurobiol 39:73-80 (2009)
REFERENCE   PMID:18617632
  AUTHORS   Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A
  TITLE     Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
  JOURNAL   Mol Pharmacol 74:1101-8 (2008)
REFERENCE   PMID:21338876
  AUTHORS   Sulzer D
  TITLE     How addictive drugs disrupt presynaptic dopamine neurotransmission.
  JOURNAL   Neuron 69:628-49 (2011)
REFERENCE   PMID:8630246
  AUTHORS   Hyman SE
  TITLE     Addiction to cocaine and amphetamine.
  JOURNAL   Neuron 16:901-4 (1996)
REFERENCE   PMID:18632938
  AUTHORS   Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I, Kumar A, Montgomery RL, Olson EN, Nestler EJ
  TITLE     Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.
  JOURNAL   J Neurosci 28:7344-9 (2008)
REFERENCE   PMID:21989194
  AUTHORS   Robison AJ, Nestler EJ
  TITLE     Transcriptional and epigenetic mechanisms of addiction.
  JOURNAL   Nat Rev Neurosci 12:623-37 (2011)
REFERENCE   PMID:14529709
  AUTHORS   Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P
  TITLE     Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.
  JOURNAL   Neuropharmacology 45:703-13 (2003)
REFERENCE   PMID:19222557
  AUTHORS   Banerjee PS, Aston J, Khundakar AA, Zetterstrom TS
  TITLE     Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and  adult brain.
  JOURNAL   Eur J Neurosci 29:465-76 (2009)
KO_PATHWAY  ko05031
///
